Daiwa Securities Group Inc. Argenx Se Transaction History

Daiwa Securities Group Inc.

$21.6 Billion
Q3 2024

A detailed history of Daiwa Securities Group Inc. transactions in Argenx Se stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 1,315 shares of ARGX stock, worth $826,240. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,315

Previous 845 55.62%

Holding current value

$826,240

Previous $363,000 96.14%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$434.22 - $551.9 $204,083 - $259,393	470 Added 55.62%	1,315 $712,000
Q2 2024 Aug 07, 2024	SELL	$356.01 - $451.55 $18,512 - $23,480	-52 Reduced 5.8%	845 $363,000
Q1 2024 May 02, 2024	SELL	$356.95 - $413.29 $225,949 - $261,612	-633 Reduced 41.37%	897 $353,000
Q4 2023 Jan 31, 2024	BUY	$338.91 - $506.01 $13,895 - $20,746	41 Added 2.75%	1,530 $582,000
Q3 2023 Nov 01, 2023	BUY	$369.35 - $548.43 $194,278 - $288,474	526 Added 54.62%	1,489 $732,000
Q2 2023 Jul 31, 2023	SELL	$360.14 - $422.58 $14,405 - $16,903	-40 Reduced 3.99%	963 $376,000
Q1 2023 May 02, 2023	BUY	$334.23 - $403.65 $110,630 - $133,608	331 Added 49.26%	1,003 $373,000
Q4 2022 Feb 06, 2023	BUY	$342.17 - $402.31 $191,957 - $225,695	561 Added 505.41%	672 $254,000
Q2 2022 Aug 09, 2022	BUY	$269.58 - $378.88 $7,548 - $10,608	28 Added 33.73%	111 $42,000
Q1 2022 Apr 29, 2022	SELL	$254.45 - $351.06 $3,053 - $4,212	-12 Reduced 12.63%	83 $26,000
Q3 2021 Nov 05, 2021	BUY	$295.0 - $350.58 $11,800 - $14,023	40 Added 72.73%	95 $29,000
Q2 2021 Aug 06, 2021	BUY	$257.11 - $319.92 $1,542 - $1,919	6 Added 12.24%	55 $17,000
Q1 2021 May 03, 2021	BUY	$268.3 - $380.31 $536 - $760	2 Added 4.26%	49 $13,000
Q4 2020 Feb 04, 2021	SELL	$248.13 - $308.36 $25,557 - $31,761	-103 Reduced 68.67%	47 $14,000
Q3 2020 Nov 02, 2020	BUY	$215.51 - $272.51 $4,525 - $5,722	21 Added 16.28%	150 $39,000
Q1 2020 May 14, 2020	BUY	$108.83 - $165.23 $761 - $1,156	7 Added 5.74%	129 $17,000
Q4 2019 Jan 31, 2020	SELL	$106.59 - $164.21 $1,492 - $2,298	-14 Reduced 10.29%	122 $20,000
Q3 2019 Nov 04, 2019	BUY	$113.31 - $150.51 $453 - $602	4 Added 3.03%	136 $15,000
Q1 2019 Apr 26, 2019	SELL	$98.85 - $134.59 $2,767 - $3,768	-28 Reduced 17.5%	132 $16,000
Q4 2018 Feb 05, 2019	BUY	$63.81 - $109.82 $10,209 - $17,571	160 New	160 $15,000

Others Institutions Holding ARGX

# of Institutions

400

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.8B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.

Account

Daiwa Securities Group Inc. Argenx Se Transaction History